The HTx project was presented by researchers Bertalan Németh (Syreon Research Institute, Hungary) and Konstantina Chalkou (University of Bern, Switzerland) at the European Multiple Sclerosis Platform's (EMSP) Annual Conference which took place on the 29 & 30 April 2022 in Madrid, Spain. HTx is a Horizon 2020 project supported by the European Union, kicking off in January 2019 and lasting for 5 years. The main aim of HTx is to create a framework for the Next Generation Health Technology Assessment (HTA) to support patient-centred, societally oriented, real-time decision-making on access to and reimbursement for health technologies throughout Europe. The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825162. Find out more : HTx project ➡️ https://www.htx-h2020.eu/ EMSP ➡️ https://emsp.org/ Syreon Research Institute ➡️ https://syreon.eu/ University of Bern ➡️ https://www.ispm.unibe.ch/index_eng.html

Not just a label -biology driven approach that fits You!
27 views

Models of Care for MS and Rare Demyelinating Diseases Specialised Centers vs Outpatient Pathways
14 views

Just Do It by Mirijam Kottomann
34 views

Menopause and MS
20 views

HOT TOPIC 2 Stem Cells Therapy
33 views

HOT TOPIC 1 Car-T Therapy by Dr. Dr. Barbara Willekens
56 views